Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
26-28 February, 2026
euroPLX 90 LisboneuroPLX 90 Lisbon
Not Confirmed
Not Confirmed
02-03 March, 2026
BIO CEO & InvestorBIO CEO & Investor
Not Confirmed
Not Confirmed
02-03 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 February, 2026
euroPLX 90 LisboneuroPLX 90 Lisbon
Industry Trade Show
Not Confirmed
02-03 March, 2026
BIO CEO & InvestorBIO CEO & Investor
Industry Trade Show
Not Confirmed
02-03 March, 2026
Digital content

20 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-expert-consensus-published-in-the-laryngoscope-recommends-papzimeos-zopapogene-imadenovec-as-the-new-standard-of-care-first-line-treatment-for-adults-with-recurrent-respiratory-papillomatosis-302665005.html

12 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/precigen-showcases-rapid-commercialization-momentum-and-growing-market-adoption-of-first-and-only-fda-approved-therapy-for-rrp-at-the-44th-annual-jp-morgan-healthcare-conference-302658244.html

05 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/precigen-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302652709.html

13 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/precigen-reports-third-quarter-2025-financial-results-and-business-updates-302614965.html

06 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/precigen-to-announce-third-quarter-2025-financial-results-and-provide-business-updates-on-november-13-302606625.html

13 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/precigen-announces-long-term-follow-up-results-highlighting-ongoing-durable-complete-responses-after-treatment-with-papzimeos-the-first-and-only-fda-approved-therapy-for-adults-with-recurrent-respiratory-papillomatosis-302581497.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE